Illumina named former NHGRI director Eric Green as chief medical officer, filling a long‑vacant role as the sequencing leader aims to accelerate clinical genomics adoption. In interviews, Green emphasized advocacy for integrating genomics into routine clinical care and Illumina’s intent to lean into diagnostic and multiomic clinical workflows. Green’s appointment follows Illumina’s strategic moves to expand clinical offerings and partnerships; the hire is positioned to bridge research innovation and regulatory, payer and clinical adoption pathways for sequencing‑based diagnostics.